Company Comparison
Spiber vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Spiber | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | San Diego |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Series A |
| Total Funding | — | $48M |
| Valuation | — | — |
What They Build
Spiber
Japanese biotech company creating synthetic spider silk and other biomaterials through fermentation technology for sustainable textile and material applications.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
AI Therapeutics
No investors listed.
Sector Overlap
Both Spiber and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.